This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Danaher to Buy BioPharma, Offers Common & Preferred Shares
by Zacks Equity Research
Danaher (DHR) to gain from the buyout of the BioPharma business. This is likely to strengthen its biologics workflow solutions business. The company offers common and preferred shares.
Carlisle (CSL) Is Up 1.77% in One Week: What You Should Know
by Zacks Equity Research
Does Carlisle (CSL) have what it takes to be a top stock pick for momentum investors? Let's find out.
ITT Tops Q4 Earnings Estimates, Makes Multiple Announcements
by Zacks Equity Research
ITT's (ITT) fourth-quarter 2018 results gain year over year from improved margins and lower tax expenses. It announces a hike in dividend rate, a share buyback program and an acquisition agreement.
Zacks.com featured highlights include: Synopsys, Progressive, Equinix, AMETEK and Carlisle
by Zacks Equity Research
Zacks.com featured highlights include: Synopsys, Progressive, Equinix, AMETEK and Carlisle
Macquarie (MIC) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Macquarie's (MIC) fourth-quarter earnings decline year over year on account of surge in operating costs along with rise in interest expenses.
Buy These 5 Stocks With Attractive Sales Growth Right Now
by Zacks Equity Research
Sales growth is an important indicator of a company's health, and its ability to sustain business. It provides investors an insight into product demand and pricing power.
CSL or DHR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CSL vs. DHR: Which Stock Is the Better Value Option?
Carlisle (CSL) in Focus: Stock Moves 5.9% Higher
by Zacks Equity Research
Carlisle (CSL) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Can Carlisle (CSL) Stock Continue to Grow Earnings?
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Carlisle (CSL).
Carlisle (CSL) Q4 Earnings Top Estimates, Up on Solid Sales
by Zacks Equity Research
Carlisle's (CSL) earnings in fourth-quarter 2018 gain from organic sales growth, acquired assets and margin improvement. Segmental business impresses.
Honeywell (HON) & Curtiss-Wright to Boost Aviation Safety
by Zacks Equity Research
Honeywell's (HON) deal with Curtiss-Wright to develop a new generation of cockpit voice and flight-data recorders will help investigators ascertain accident cause, thereby making aviation safer.
Carlisle (CSL) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Carlisle (CSL) delivered earnings and revenue surprises of 30.58% and 2.04%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Carlisle to Buy Back 5M Shares, Announces Quarterly Dividend
by Zacks Equity Research
Carlisle (CSL) is committed toward rewarding its shareholders handsomely through dividend payments and share buybacks.
Honeywell's (HON) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Honeywell's (HON) Q4 earnings and revenues outpace estimates on the back of strength in its long-cycle businesses in U.S. defense, commercial aerospace as well as warehouse automation.
Carlisle (CSL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Carlisle (CSL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Danaher (DHR) Q4 Earnings & Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
Danaher's (DHR) Q4 earnings jump year over year on the back of solid performance across all its segments.
3M (MMM) Beats Q4 Earnings Estimates, Revises '19 View Down
by Zacks Equity Research
3M's (MMM) fourth-quarter 2018 results gain from decrease in costs of sales and operating expenses as well as lower tax expenses. It lowers earnings projection for 2019.
GE to Report Q4 Earnings: Will Power Segment Issues Hurt?
by Zacks Equity Research
General Electric's (GE) Power segment faces headwinds from growing popularity of renewable resources and macroeconomic issues. The reorganization plan, when implemented, might bring in change.
GE to Post Q4 Earnings: Will Aviation & Renewable Energy Aid?
by Zacks Equity Research
Rise in air travel to benefit General Electric's (GE) Aviation segment while improved shipments and project builds will strengthen the Renewable Energy segment.
Crane (CR) Beats on Q4 Earnings, Hikes Quarterly Dividend
by Zacks Equity Research
Crane's (CR) fourth-quarter 2018 results benefit from growth in organic sales, acquired assets and margin improvement. It hikes quarterly dividend rate by 11%.
CSL or DHR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CSL vs. DHR: Which Stock Is the Better Value Option?
United Technologies' (UTX) Q4 Earnings and Revenues Beat
by Zacks Equity Research
United Technologies' (UTX) Q4 earnings jump year over year on the back of solid performance across all its segments.
Zacks.com featured expert Kevin Matras highlights: Carlisle, Berry Global, Synopsys, VMware and Alaska Air
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Carlisle, Berry Global, Synopsys, VMware and Alaska Air
Add These 5 Stocks With Solid Sales Growth to Your Portfolio
by Zacks Equity Research
Sales growth is an important metric for gauging a company's future performance.
Honeywell Chosen by ZPC for Petrochemicals Project in China
by Zacks Equity Research
Honeywell's (HON) unit, Honeywell UOP, gets selected by ZPC to provide a range of process technology for its integrated refining and petrochemical complex in Zhoushan.